Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeerleder, S.
Right arrow Articles by Wuillemin, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeerleder, S.
Right arrow Articles by Wuillemin, W. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 August 2001, Vol. 98, No. 3, pp. 890-891

CORRESPONDENCE

To the editor:

Bacillus Calmette-Guérin sepsis: shift of an intended local toward a detrimental systemic cytotoxic immune response

A 56-year-old male patient was admitted to our intensive care unit (ICU) because of sepsis with multiple organ failure. Twelve days before admission, the patient underwent adjuvant renal instillation of bacillus Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, after subtotal resection of the right renal pelvis due to papillary transitional cell carcinoma. Bone marrow aspiration revealed multiple epitheloid-cell granulomas with central necrosis, and a positive polymerase chain reaction (PCR) for Mycobacterium tuberculosis complex was found in the tracheobronchial secretion. Diagnosis of BCG sepsis was made. Despite extensive and adequate therapy, multiple organ failure persisted and the patient died after 35 days in the ICU. On autopsy, multiple epitheloid-cell granulomas with central necrosis were found in the spleen, bone marrow, and lungs.

Serial blood samples were collected during the first 5 days in the ICU, in order to evaluate levels of tumor necrosis factor-alpha (TNF-alpha ), interferon gamma  (IFN-gamma ), interleukin-6 (IL-6), IL-8, IL-10, and granzyme A (GrA). Results are given in Table 1.

                              
View this table:
[in this window]
[in a new window]
 
Table 1. Cytokine and granzyme levels

Instillation of BCG is used to enhance the cytotoxic activity by natural killer (NK) cells and cytotoxic T (CTL) cells against transitional cancer cells.1,2 Upon stimulation with BCG, macrophages produce IL-12 and TNF-alpha , which stimulate NK cells to produce IFN-gamma and T cells to differentiate into the T helper type 1 (TH1) subset, then generating IL-2 and IFN-gamma . The released IFN-gamma potentiates macrophages' microbicidal activity, phagocytosis, oxidative burst capability, and IL-12 production (positive feedback), but in synergy with IL-2 it also activates and enhances cytotoxic properties of NK and CTL cells.3

In our patient, elevated plasma levels of IL-12, INF-gamma , and TNF-alpha revealed a cytokine pattern typical for activated macrophages and TH1 cells. The concomitant rise in granzyme A in plasma, a specific marker for CTL- and NK-cell activation, strongly suggested enhanced cell-mediated cytotoxicity. The appearance of BCG in the circulation led to a systemic inflammatory response, as reflected by the elevated proinflammatory cytokines IL-6 and IL-8. The anti-inflammatory cytokine IL-10, however, which was reported to play a role in down-regulation of IL-12 production, was hardly detectable in our patient.3

Upon microbial stimulation, patients with a IL-12 receptor deficiency are unable to generate sufficient amounts of IFN-gamma .4 Patients with a complete IFN-gamma receptor deficiency were reported to suffer from spontaneous recurrent disseminated mycobacterial infections, thereby showing characteristic immature leprosislike granulomas in tissue.5 In contrast, disseminated mature granulomas found in our patient's tissue and elevated levels of IL-12, IFN-gamma , TNF-alpha , and GrA suggest the local cell-mediated cytotoxicity exhibited by macrophages, NK cells, and CTL cells to be sufficient. But systemic release of IL-12, IFN-gamma , and TNF-alpha due to BCG appearance in circulation might have led to a systemic activation and enhancement of cytotoxicity by NK and CTL cells, as reflected by elevated GrA levels. At least in animal models, there is strong evidence that activation of NK cells contributes to the development of multiple organ failure.6 Hence, due to systemic release of IL-12, TNF-alpha , and IFN-gamma , enhanced cytotoxicity elaborated by NK and CTL cells might have been a key step in the development of multiple organ failure in our patient.

Sepsis as a severe but rare complication of BCG-instillation therapy occurs in 0.4% of treated patients.1 We show for the first time that, once in systemic circulation, BCG systemically activates and enhances NK- and CTL-cell-mediated cytotoxicity and, therefore, might contribute to the development of multiple organ failure and, hence, to fatal outcome.


Sacha Zeerleder, C. Erik Hack, Christoph Caliezi, Renate Hebeisen, and Walter A. Wuillemin
Correspondence: W. A. Wuillemin, Division of Hematology, Department of Internal Medicine, Kantonsspital, 6000 Lucerne 16, Switzerland

Acknowledgments

Supported by a grant from the Swiss National Foundation for Scientific Research (no. 32-55312.98) and by an unrestricted grant from Aventis Behring Switzerland.

References

1. Mungan NA, Witjes JA. Bacille Calmette-Guérin in superficial transitional cell carcinoma. Br J Urol. 1998;82:213-223[Medline] [Order article via Infotrieve].

2. Schamhart DHJ, de Boer EC, de Reijke TM, Kurth KH. Urinary cytokines reflecting the immunological response in the urinary bladder to biological response modifiers: their practical use. Eur Urol. 2000;37(suppl 3):16-23.

3. Romani L, Puccetti P, Bistoni F. Interleukin-12 in infectious diseases. Clin Microbiol Rev. 1997;10:611-636[Abstract].

4. Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science. 1998;280:1432-1435[Abstract/Free Full Text].

5. Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med. 1996;335:1956-1961[Free Full Text].

6. Carson WE, Yu H, Dierksheide J, et al. A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol. 1999;162:4943-4951[Abstract/Free Full Text].


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeerleder, S.
Right arrow Articles by Wuillemin, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeerleder, S.
Right arrow Articles by Wuillemin, W. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020